01 7VERTEX PHARMS INC
01 712214083
01 7Blank
01 7Y
01 72033-02-27
Patent Expiration Date : 2033-02-27
US Patent Number : 12214083
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-4127
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 12214083
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4141
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
US Patent Number : 12214083
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-4127
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
US Patent Number : 12214083
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-4126
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
US Patent Number : 12214083
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-4128
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
US Patent Number : 12214083
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-4126
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 12214083
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4141
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
